Tag / Transgene
-
![]()
Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors
Novel Oncolytic Virotherapies will be developed by Transgene, based on its next generation Invir.IOTM Platform and expressing Randox’ Single-domain Antibodies (SdAb) Strasbourg (France) and Belfast (Northern Ireland), October 2, 2017, 5:45 p.m.
Loading posts...
